Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)

Hemosiderosis

Non-invasive Quantification of Liver Iron With MRI Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content Efficacy Study in Removing Excess Iron From the Heart Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients Pharmacogenetic Study in Patients Received Iron Chelating Agent Safety, Tolerability, and Efficacy of Deferasirox in MDS A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)